Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
Murilo Wendeborn RodriguesJosé A CardilloAndré MessiasRubens C SiqueiraIngrid U ScottRodrigo JorgePublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2019)
In eyes with pDME after 24 weeks of treatment with prn-IVB, there was no difference between continued treatment with prn-IVB versus a treatment switch to prn-IVT with respect to mean BCVA or mean CST at week 48. However, BCVA was stable in the prn-IVB group, while prn-IVT was associated with BCVA reduction from baseline and a higher risk of IOP elevation.